These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Development of a single vector system that enhances trans-splicing of SMN2 transcripts. Coady TH, Baughan TD, Shababi M, Passini MA, Lorson CL. PLoS One; 2008 Mar; 3(10):e3468. PubMed ID: 18941511 [Abstract] [Full Text] [Related]
8. Therapeutics development for spinal muscular atrophy. Sumner CJ. NeuroRx; 2006 Apr; 3(2):235-45. PubMed ID: 16554261 [Abstract] [Full Text] [Related]
9. 5-(N-ethyl-N-isopropyl)-amiloride enhances SMN2 exon 7 inclusion and protein expression in spinal muscular atrophy cells. Yuo CY, Lin HH, Chang YS, Yang WK, Chang JG. Ann Neurol; 2008 Jan; 63(1):26-34. PubMed ID: 17924536 [Abstract] [Full Text] [Related]
10. Delivery of bifunctional RNAs that target an intronic repressor and increase SMN levels in an animal model of spinal muscular atrophy. Baughan TD, Dickson A, Osman EY, Lorson CL. Hum Mol Genet; 2009 May 01; 18(9):1600-11. PubMed ID: 19228773 [Abstract] [Full Text] [Related]
11. Correction of SMN2 Pre-mRNA splicing by antisense U7 small nuclear RNAs. Madocsai C, Lim SR, Geib T, Lam BJ, Hertel KJ. Mol Ther; 2005 Dec 01; 12(6):1013-22. PubMed ID: 16226920 [Abstract] [Full Text] [Related]
12. Is RNA manipulation a viable therapy for spinal muscular atrophy? Horne C, Young PJ. J Neurol Sci; 2009 Dec 15; 287(1-2):27-31. PubMed ID: 19758605 [Abstract] [Full Text] [Related]
13. Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model. Hua Y, Sahashi K, Rigo F, Hung G, Horev G, Bennett CF, Krainer AR. Nature; 2011 Oct 05; 478(7367):123-6. PubMed ID: 21979052 [Abstract] [Full Text] [Related]